Tag: Andrew Gwynne

The below Parliamentary question was asked by Andrew Gwynne on 2016-07-19.

To ask the Secretary of State for Business, Energy and Industrial Strategy, what his Department’s plans are for the Office for Life Sciences; and if he will make a statement.

Joseph Johnson

The Office for Life Sciences was established in 2011 to support the development and adoption of 21st century health and life sciences technology, delivering the improved patient outcomes and increasing wider growth and prosperity. This agenda remains a core part of the Government’s plans for a comprehensive industrial strategy and for transforming health and care.

The below Parliamentary question was asked by Andrew Gwynne on 2016-09-15.

To ask the Secretary of State for Transport, what advice his Department offer local authorities on issuing Hackney carriage or private hire driver licences to people based outside their local authority area.

Andrew Jones

Local authorities can issue licences to prospective Hackney Carriage and Private Hire Vehicle drivers irrespective of where the driver lives. The Department provides Best Practice Guidance for local authorities to help them develop their own standards for taxi and PHV operators, drivers and vehicles.

The below Parliamentary question was asked by Andrew Gwynne on 2016-10-14.

To ask the Prime Minister, whether any government Minister was present at her meeting with Rupert Murdoch held in September 2016.

Mrs Theresa May

Details of Ministers’ meetings with external organisations, including with newspaper and other media proprietors, editors and senior executives, are published on a quarterly basis and made available on the gov.uk website.

The below Parliamentary question was asked by Andrew Gwynne on 2015-10-28.

To ask the Secretary of State for Health, pursuant to the Answer of 14 October 2015 to Question 11110, how much the NHS spent on cancer services in each year since 2012-13; and what the year-on-year change in that amount was in real terms.

Jane Ellison

Overall National Health Service expenditure on cancer services is not available for 2013-14 or 2014-15. NHS England has published clinical commissioning group (CCG) level expenditure on cancer for 2013-14, which was estimated to be £2.8 billion. CCGs are currently in the process of preparing estimates of expenditure for cancer services in 2014-15.

CCG expenditure is a proportion of overall NHS expenditure, as NHS England commissions some cancer services directly. NHS England is currently reviewing the data on direct commissioning expenditure and plans to publish this when finalised.

The below Parliamentary question was asked by Andrew Gwynne on 2015-11-02.

To ask the Secretary of State for Justice, what estimate he has made of the value of stationery that has been (a) lost and (b) stolen from his Department in each of the last five fiscal years; and what the cost was of replacing such stationery.

Mr Shailesh Vara

The information requested could only be obtained at disproportionate cost.

The below Parliamentary question was asked by Andrew Gwynne on 2015-11-24.

To ask the Secretary of State for Health, what estimate he has made of the (a) forecast reduction in cases of and deaths from infection by Group C meningococcal disease as a result of the introduction of the meningitis C vaccine to the UK schedule in 1999, (b) number of meningitis C vaccinations administered in each year since that programme began and (c) cost of delivering that programme in each year since 1999.

Jane Ellison

Deaths have fallen from 110 in 1998/99 to an annual average of 3 deaths over the last 10 years. Annual MenC cases and deaths have therefore been respectively 97% and 96% lower in the last 10 years than in the year before vaccination was available.

Routine immunisation programmes with MenC containing vaccines have changed since 1999 and this has affected the ability to collect estimate annual numbers of doses administered for each vaccine offered but currently around 96% of infants receive MenC vaccine and 93% of one year olds receive their MenC-Hib booster in England by their second birthday. Coverage data are not routinely collected on the third dose in adolescence (currently MenACWY vaccine) which began in the 2013-2014 school year.

The administrative costs for the MenC programme are included in the global sum payment to general practitioners (managed by NHS England) which covers the costs of providing essential and additional primary care services.

The below Parliamentary question was asked by Andrew Gwynne on 2015-12-17.

To ask the Secretary of State for Health, if he will maintain patient access to technologies considered through commissioning through evaluation programmes during that evaluation.

George Freeman

There are two main phases for any treatments entered into NHS England’s Commissioning through Evaluation (CtE) programme.

During the first phase, an agreed number of patients are recruited to the scheme within just a few participating centres across England. This enables patients to benefit from the skills and expertise in each centre, within an evaluation programme, whilst detailed clinical and patient experience data are collected.

Once the total number of patients have been treated, the scheme enters an analysis phase. Whilst any patients already treated under the scheme will continue to receive appropriate follow up care, no new patients will be funded by NHS England during the analysis phase.

This ensures that NHS England directs the majority of public funds to evidence based care and also means that dedicated CtE programme funding can then be redirected to support patient recruitment in another area of specialised care where further evaluation data is needed.

This represents a continuation of NHS England’s published policy position for the treatment concerned (i.e. that the treatment is not routinely commissioned by the National Health Service).

The below Parliamentary question was asked by Andrew Gwynne on 2016-01-14.

To ask the Secretary of State for Work and Pensions, what projects his Department plans to fund through the £40 million allocated to the Health and Work Innovation Fund.

Priti Patel

The Work and Health innovation fund will be used to build an evidence base for what works to improve employment and health outcomes.

This evidence base will enable the Work and Health Unit to develop proposals for Longer Term reform across Work and health Systems The Unit is currently working with partners including NHS England to develop these proposals.

The below Parliamentary question was asked by Andrew Gwynne on 2016-01-27.

To ask the Secretary of State for Defence, whether his Department has an insurance policy in place for civilian residents on the land around RAF Northolt to cover possible damage to their properties.

Mark Lancaster

The Ministry of Defence does not purchase insurance policies in the UK but accepts its own risks and acts as its own insurer.

The below Parliamentary question was asked by Andrew Gwynne on 2016-01-28.

To ask the Secretary of State for Health, what the budget was for the Rare and Imported Pathogens Laboratory in each of the last five years.

Jane Ellison

Public Health England (PHE) was formed on 1 April 2013; below are budgets for the Rare and Imported Pathogens Laboratory (RIPL) for each year since PHE’s formation. The RIPL was previously part of the Health Protection Agency, whose functions transferred to PHE.

2013/14 (Actual)	2014/15 (Actual)	2015/16 (Budget)
£3,491,300	£3,667,600	£3,465,300